Traduction de «abnormal occurrences reporting system association » (Anglais → Français) :

Agreement between the EAEC, represented by the Commission of the EC and nine other bodies for the regulation of the Abnormal Occurrences Reporting System Association (AORSA)

Abnormal Occurrences Reporting System | AORS [Abbr.]

Civil Aviation Daily Occurrence Reporting System

CATA Daily Occurrence Reporting System

Aircraft Services Occurrence Reporting System

An extremely rare tumour association characterised by dual predisposition to melanoma and neural system tumours (typically astrocytoma). Fewer than 20 affected families have been reported to date. Affected individuals had cutaneous melanoma in associ

This syndrome is characterized by the association of global developmental delay, osteopenia and skin anomalies. To date, only three cases (two brothers and one unrelated girl) have been reported. Central nervous system anomalies manifest as poor lang

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include sel ...[+++]f-report data, analysis of blood and other body fluids, characteristic physical and psychological symptoms, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

An extremely rare genetic glycogen storage disease reported in one patient to date. Clinical signs included muscle weakness, cardiac arrhythmia associated with accumulation of abnormal storage material in the heart and glycogen depletion in skeletal

The two main criteria associated with the reporting process are the spatial or temporal clustering of cases of disease with a risk of propagation between Member States within the Community (criterion 2) and the occurrence of a disease that might require coordinated and timely Community action to contain it (criterion 4).

Each EU country and the European Aviation Safety Agency (EASA) must set up mandatory and voluntary reporting systems for the collection, evaluation, processing, analysis and storage of occurrences reported, including those reported to them by the organisations.

Each organisation established in an EU country must set up mandatory and voluntary reporting systems for the collection, evaluation, processing, analysis and storage of occurrences reported.

The comprehensive list of occurrences to be reported under mandatory systems is detailed in Commission Implementing Regulation (EU) 2015/1018